drugset / Trial / NCT03063931

Pain and Magnesium

NCT03063931

Phase 2 Unknown 100 enrolled University Hospital, Clermont-Ferrand
RandomizedParallel-groupDouble-blindPrevention

Summary

In breast cancer patients undergoing a mastectomy, the aim of this study is to evaluate if the magnesium administered for 6 weeks starting two weeks before the surgery induces a decrease of pain intensity one month post-mastectomy compared to the placebo group.

Timeline

Start
2017-03
Primary completion
2019-03
Completion
2019-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 100 mg Oral

Indications

No indication recorded.